Past DCB Events
NCI staff shared information about Notices of Funding Opportunities for the Human Tumor Atlas Network (HTAN).
Nov. 9, 2023
Commemorated the 40th anniversary of pivotal discoveries that launched the field of cancer epigenetics.
Oct. 20, 2023
Discussed research and implementation strategies to advance the goal of hepatitis elimination.
Mar. 4, 2021 – Sept. 14, 2023
Translational Systems Biology Symposium: New Computational Technologies and Trial Designs for a Continuum of Personalized Therapy
Focused on utilizing patient clinical and -omic data with systems biology models in clinical settings.
Aug. 24-25, 2023
Brough together junior investigators who build and apply novel tools to better understand cancer.
Aug. 17 - 18, 2023
Summer undergraduate researchers shared their cancer biology projects and networked with members of the cancer research community at the NIH.
July 13 - 14, 2023
Assessed the current state of the science of using signatures from “omic” data types to link environmental exposures to cancer
June 29 - 30, 2023
Examined mechanisms of stem cell immune privilege and how they may be related to immune evasion in tumors.
May 1, 2023
DCB staff gave presentations and interacted with researchers at the 2023 AACR Annual Meeting.
Apr. 14 - 19, 2023
Examined the importance of leveraging advances across fields to
accelerate cancer research and discovery through Artificial Intelligence (AI)
April 3-4, 2023
Explored the intersection of data visualization and cancer.
Aug. 31, 2020 - Dec. 1, 2022
Enhanced the understanding of opportunities for targeting fusion oncoproteins through emerging chemoproteomic methods.
Aug. 19 - Oct. 21, 2022
Identified opportunities that will shape the landscape of future brain metastasis research.
Sept. 29-30, 2022
Examined the role of IDPs in cancer biology.
Sept. 26, 2022
Discussed the role of post-translational modifications in tumor biology.
Sept. 22-23, 2022
Examined the current state of the art technologies, as well as outstanding scientific gaps and opportunities in computational immuno-oncology (IO).
Sept. 19, 2022
Explored alterations in RNA metabolism as a novel means to modulate genome stability.
Dec. 6-7, 2021
Examined the state of the science of mutation signatures in several key areas: normal and cancer tissues, exogenous and endogenous processes, analytical approaches, and translational aspects.
Facilitated cross-disciplinary interactions and identified research opportunities at the intersection of cancer biology and the physical sciences.
Mar. 23 - 31, 2021
Examined the status of the science on diet and cancer metabolism across different biological levels.
Jul. 14-15, 2021
Discussed research priorities to improve the understanding of connections between environmental exposures and biological mechanisms that contribute to early-onset colorectal cancer.
Sep. 24-25, 2020
Celebrated a decade of NCI-supported research in physical sciences in oncology.
Sept. 21-23, 2020.
Explored how different models represent human biology for clinical translation and ways to inform the research community about choosing the most effective models for immuno-oncology research.
Jul. 9-10, 2020
Examined the current state of geroscience research.
Nov. 4-5, 2019
Examined research advances in tumor-immune interactions and highlighted the critical functions of stromal cell types within the context of tumor heterogeneity.
Sep. 19-20, 2019
Explored insights into the progression of gynecologic cancers from benign conditions.
Apr. 24-26, 2019